3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
311
Neoplasm Metastasis
38
Neoplasms
22
Advanced Breast Cancer
19
Ovarian Neoplasms
18
Carcinoma, Non-Small-Cell Lung
14
Endometrial Neoplasms
11
Prostatic Neoplasms
10
Hereditary Sensory and Autonomic Neuropathies
10
Triple Negative Breast Neoplasms
8
Colorectal Neoplasms
6
Breast Cancer Metastatic
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Recurrence
5
Carcinoma, Ovarian Epithelial
5
Neoplasms by Site
4
Multiple Endocrine Neoplasia Type 1
4
Breast Diseases
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Head and Neck Neoplasms
3
Fallopian Tube Neoplasms
3
Carcinoma, Lobular
3
Uterine Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Interventions
Fulvestrant
2
vistusertib
1
proto-oncogene protein c-fes-fps
1
capivasertib
1
Transurethral Resection of Bladder
1
Hydroxychloroquine
1
Everolimus
1
Estrogens
1
Estradiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Estrogen Receptor Positive Breast Cancer
×
Fulvestrant
×
Clear all
NCT01992952
2025-11-26
FAKTION
Velindre NHS Trust
Phase 1/2
Active not recruiting
149 enrolled
NCT02216786
2024-12-02
MANTA
Queen Mary University of London
Phase 2
Completed
333 enrolled